XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.1
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
STOCK-BASED COMPENSATION

7. STOCK-BASED COMPENSATION

In May 2020, our shareholders approved the DIRTT Environmental Solutions Ltd. Long-Term Incentive Plan (the “2020 LTIP”) at the annual and special meeting of shareholders. The 2020 LTIP gives the Company the ability to award options, share appreciation rights, restricted share units, restricted shares, dividend equivalent rights granted in connection with restricted share units, vested share awards, and other share-based awards and cash awards to eligible employees, officers, consultants and directors of the Company and its affiliates. In accordance with the 2020 LTIP, the sum of (i) 5,850,000 common shares plus (ii) the number of common shares subject to stock options previously granted under the Company’s Amended and Restated Incentive Stock Option Plan (the “Stock Option Plan”) that, following May 22, 2020, expire or are cancelled or terminated without having been exercised in full have been reserved for issuance under the 2020 LTIP.       

The Company also maintains the DIRTT Environmental Solutions Ltd. Deferred Share Unit Plan for Non-Employee Directors pursuant to which deferred share units (“DSUs”) are granted to the Company’s non-employee directors. DSUs are settled solely in cash.

Prior to the approval of the 2020 LTIP, the Company granted awards of options under the Stock Option Plan and awards of performance share units (“PSUs”) under the DIRTT Environmental Solutions Ltd. Performance Share Unit Plan (the “PSU Plan”). Following the approval of the 2020 LTIP, no further awards will be made under either the Stock Option Plan or the PSU Plan, but both remain in place to govern the terms of any awards that were granted pursuant to such plans and remain outstanding.

Stock-based compensation expense

 

 

 

For the Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Equity-settled awards

 

 

796

 

 

 

663

 

Cash-settled awards

 

 

298

 

 

 

(202

)

 

 

 

1,094

 

 

 

461

 

 

The following summarizes PSUs, DSUs and RSUs (as defined below) granted, exercised, forfeited and expired during the periods:

 

 

 

RSU Time-

 

 

RSU Performance-

 

 

 

 

 

 

 

 

 

 

 

Based

 

 

Based

 

 

DSU

 

 

PSU

 

 

 

Number of

 

 

Number of

 

 

Number of

 

 

Number of

 

 

 

units

 

 

units

 

 

units

 

 

units

 

Outstanding at December 31, 2019

 

 

-

 

 

 

-

 

 

 

132,597

 

 

 

223,052

 

Granted

 

 

-

 

 

 

-

 

 

 

83,915

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(25,581

)

Outstanding at March 31, 2020

 

 

-

 

 

 

-

 

 

 

216,512

 

 

 

197,471

 

Outstanding at December 31, 2020

 

 

2,414,066

 

 

 

200,000

 

 

 

363,664

 

 

 

197,471

 

Granted

 

 

1,890,987

 

 

 

878,601

 

 

 

31,837

 

 

 

-

 

Forfeited

 

 

(5,588

)

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding at March 31, 2021

 

 

4,299,465

 

 

 

1,078,601

 

 

 

395,501

 

 

 

197,471

 

Restricted share units (time-based vesting)

Restricted share units that vest based on time have an aggregate time-based vesting period of three years and generally one-third of the RSUs vest every year over a three-year period from the date of grant (“RSUs”). At the end of a three-year term, the RSUs will be settled by way of the provision of cash or shares to employees (or a combination thereof), at the discretion of the Company. The weighted average fair value of the RSUs granted was C$3.11 (2020 – C$2.05) which was determined using the closing price of the Company’s common shares on their respective grant dates.

Restricted share units (performance-based vesting)

The Company granted to certain executives and senior employees restricted share units with service and performance-based conditions for vesting (the “PRSUs”). If the Company’s share price increases to certain values for 20 consecutive trading days, as outlined below, a percentage of the PRSUs will vest at the end of the three-year service period. The grant date fair value of the PRSUs were valued using the Monte Carlo valuation method and determined to have a weighted average grant date fair value of C$3.27 (2020 – C$1.70).  

 

 

% of PRSUs vesting

 

33.3%

50.0%

66.7%

100.0%

150.0%

2021 PRSUs

$3.00

-

$4.00

$5.00

$7.00

2020 PRSUs

-

C$3.00

-

C$4.00

C$6.00

Deferred share units

The fair value of the liability and the corresponding expense is charged to profit or loss at the grant date. Subsequently, at each reporting date between the grant date and settlement date, the fair value of the liability is remeasured with any changes in fair value recognized in profit or loss for the year. DSUs outstanding at March 31, 2021 had a fair value of $1.2 million which is included in other liabilities on the balance sheet (December 31, 2020 – $0.9 million).

Performance share units

Under the terms of the PSU Plan, PSUs granted vest at the end of a three-year term. At the end of a three-year term, employees will be awarded cash at the discretion of the board of directors of the Company, calculated based on certain Adjusted EBITDA, total shareholder return, or revenue growth related to performance conditions.

The fair value of the liability and the expense attributable to the vesting period is charged to profit or loss at the grant date. Subsequently, at each reporting date between the grant date and settlement date, the fair value of the liability is remeasured with any changes in fair value recognized in profit or loss. As at March 31, 2021, outstanding PSUs had a fair value of $0.1 million which is included in other liabilities on the balance sheet (December 31, 2020 – $0.1 million).                  

Options         

The following summarizes options granted, exercised, forfeited and expired during the periods:   

 

 

 

Number of

 

 

Weighted average

 

 

 

options

 

 

exercise price C$

 

Outstanding at December 31, 2019

 

 

6,156,652

 

 

 

6.49

 

Forfeited

 

 

(523,549

)

 

 

6.80

 

Outstanding at March 31, 2020

 

 

5,633,103

 

 

 

6.46

 

Outstanding at December 31, 2020

 

 

4,774,328

 

 

 

6.52

 

Forfeited

 

 

(3,213

)

 

 

6.81

 

Outstanding at March 31, 2021

 

 

4,771,115

 

 

 

6.52

 

Exercisable at March 31, 2021

 

 

2,065,938

 

 

 

6.35

 

 

In 2018, 1,725,000 stock options were granted to an executive with performance conditions for vesting. For 825,000 stock options, vesting is upon an increase in the Company’s share price to C$13.26, and for 900,000 stock options, vesting is upon an increase in the Company’s share price to C$19.89. These options were valued using the Monte Carlo valuation method and determined to have a weighted average grant fair value of C$2.14 on original grant. These awards were accounted for at the fair value attributable to the vesting period until October 9, 2019 when these were reclassified to equity accounting and were re-valued at a weighted average fair value of C$0.83.

Range of exercise prices outstanding at March 31, 2021:

 

 

Options outstanding

 

 

Options exercisable

 

 

 

 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

 

 

average

 

 

average

 

 

 

 

 

 

average

 

 

average

 

 

 

Number

 

 

remaining

 

 

exercise

 

 

Number

 

 

remaining

 

 

exercise

 

Range of exercise prices

 

outstanding

 

 

life

 

 

price C$

 

 

exercisable

 

 

life

 

 

price C$

 

C$4.01 – C$5.00

 

 

22,537

 

 

 

3.64

 

 

 

4.12

 

 

 

7,513

 

 

 

3.64

 

 

 

4.12

 

C$5.01 – C$6.00

 

 

669,236

 

 

 

0.64

 

 

 

5.76

 

 

 

669,236

 

 

 

0.64

 

 

 

5.76

 

C$6.01 – C$7.00

 

 

3,298,644

 

 

 

2.54

 

 

 

6.38

 

 

 

1,126,772

 

 

 

2.59

 

 

 

6.34

 

C$7.01 – C$8.00

 

 

780,698

 

 

 

3.13

 

 

 

7.84

 

 

 

262,417

 

 

 

3.13

 

 

 

7.84

 

Total

 

 

4,771,115

 

 

 

 

 

 

 

 

 

 

 

2,065,938

 

 

 

 

 

 

 

 

 

 

Dilutive Instruments

For the three months ended March 31, 2021, 4.8 million options (2020 – 5.6 million), 4.4 million RSUs and PRSUs (2020 – nil) and 11.0 million shares which would be issued if the principal amount were settled in our common shares at the quarter end share price (2020 – nil) were excluded from the diluted weighted average number of common shares calculation as their effect would have been anti-dilutive to the net loss per share.